Independent directory of IV ketamine, Spravato, and at-home options across Clark and Washoe counties.
Estimate Nevada costNevada's ketamine treatment market is heavily concentrated in Clark County — Las Vegas, Henderson, and Summerlin — with Washoe County (Reno, Sparks) hosting most of the remainder. The state is regulated by the Nevada State Board of Medical Examiners with controlled-substance oversight from the Nevada Board of Pharmacy and the DEA. The state PDMP is queried for controlled-substance prescribing.
About 70% of Nevada ketamine providers operate in Clark County. We list both Strip-adjacent and Henderson/Summerlin clinics.
Washoe County hosts the remainder; northern Nevadans sometimes consider Lake Tahoe area providers (CA-side).
Nevada prescribers query the state PDMP for controlled-substance dispensing, which includes ketamine.
Out-of-state patients sometimes seek treatment while in Las Vegas; clinics typically require established residency or extended follow-up plan.
Per session and full course for IV, Spravato, IM, and sublingual.
Information, not advice. Cost ranges are typical published per-session ranges and may not reflect a specific clinic. Consult a licensed provider for an individualized quote.
Board of Medical Examiners, Nevada PDMP, REMS requirements.
Information only. Regulations change. Confirm current rules with the state medical board and DEA before booking treatment.
Commercial, Medicare, Nevada Medicaid, VA.
Information only. Confirm benefits with your plan and the treating clinic before scheduling.
Las Vegas, Henderson, and Summerlin host the bulk of Nevada ketamine providers. Reno and Sparks account for most of the remainder. Outside Clark and Washoe counties, ketamine clinics are rare; Elko, Carson City, and rural Nevada patients often travel to the larger metros or to neighboring states.
The Nevada State Board of Medical Examiners licenses MDs; the Nevada State Board of Osteopathic Medicine licenses DOs. License verification is available at medboard.nv.gov. Nevada operates a prescription drug monitoring program that prescribers must query before issuing controlled-substance prescriptions, including ketamine.
Nevada permits telemedicine prescribing of controlled substances when the prescriber holds a Nevada license and conducts a synchronous video evaluation, subject to current DEA controlled-substance telehealth rules. At-home ketamine telehealth currently operates under the DEA's extended flexibility.
Major psychiatric practices in Las Vegas, Henderson, and Reno are typically Spravato REMS-certified. Nevada Medicaid (Nevada Check Up / Medicaid managed care) generally covers Spravato for treatment-resistant depression with prior authorization.
Visitors sometimes seek ketamine treatment while in Las Vegas. Most reputable clinics will not provide a full induction course to non-residents because follow-up care and integration are essential. A single visit may not be clinically appropriate. Ask the clinic about their out-of-state patient policy before booking.
Information, not advice. Verify directly with the Nevada State Board of Medical Examiners.
IV vs Spravato vs IM vs sublingual lozenge.
| IV ketamine | Spravato (esketamine) | IM ketamine | Sublingual lozenge | |
|---|---|---|---|---|
| FDA status | Off-label (Schedule III anesthetic) | FDA-approved 2019 for TRD; 2020 for MDD with acute suicidality | Off-label | Off-label, compounded |
| Setting | In-clinic, IV pump, monitored | REMS-certified clinic, 2-hr observation | In-clinic injection, monitored | At home (often telehealth-prescribed) |
| Typical dose | 0.5 mg/kg over 40 min | 56 mg or 84 mg nasal spray | 0.5–1.0 mg/kg | 100–400 mg sublingual |
| Induction protocol | 6 sessions over 2–3 weeks | 8 sessions over 4 weeks (2×/week) | 4–6 sessions over 2–3 weeks | Variable; weekly to 3×/week |
| Maintenance | Boosters every 2–6 weeks | Weekly then biweekly per label | Boosters every 3–6 weeks | Variable, prescriber-directed |
| Insurance coverage | Rare; usually cash-pay | Most commercial, Medicare Part B, most Medicaid (PA required) | Rare; usually cash-pay | Rare; usually cash-pay |
| Typical cost / session | $350–$950 cash | $0–$200 with insurance; $600–$1,200 cash | $200–$575 cash | $150–$425 cash (plus Rx) |
| Driving | No driving for 24 hr | No driving for 24 hr (REMS rule) | No driving for 24 hr | No driving for 24 hr after dose |
| Onset of response | Within hours to days | Within hours to days | Within hours to days | Slower; days to weeks |
Information only — not a treatment recommendation. Best modality depends on diagnosis, insurance, and clinician assessment. The FDA has approved only Spravato (esketamine) for psychiatric use; IV, IM, and lozenge ketamine are prescribed off-label.
Yes. Ketamine is a federal Schedule III controlled substance, and Nevada-licensed physicians may prescribe and administer it for on-label and off-label uses. The Nevada State Board of Medical Examiners (MDs) and the Nevada State Board of Osteopathic Medicine (DOs) license prescribers.
Nevada Medicaid managed care plans generally cover Spravato (esketamine) for treatment-resistant depression with prior authorization and documentation of failed antidepressant trials. Confirm current PDL status with your plan.
Currently yes, under the DEA's extended telehealth flexibility for controlled substances. Provider must be Nevada-licensed and conduct a synchronous video evaluation. The DEA's pending Special Registration rule may restrict at-home telehealth ketamine.
IV ketamine in Nevada typically runs $425–$800 cash per session. Spravato copays range from near-zero with commercial insurance to $600–$1,200 cash. See the cost estimator.
Most reputable Nevada clinics will not provide a full ketamine course to non-residents because follow-up care is clinically essential. A single "vacation" session is generally not appropriate. Ask each clinic about their out-of-state patient policy.
Few. Carson City, Elko, and rural Nevada have very limited access; most patients travel to Las Vegas or Reno or consider clinics in neighboring Utah, California, or Arizona.
IV ketamine is off-label and almost always cash-pay; Spravato is FDA-approved esketamine nasal spray administered at REMS-certified clinics and typically covered by insurance. See the comparison table above.
Use the tools to estimate cost, check Spravato coverage, and review modalities. Verify any clinic's licensure with the Nevada State Board of Medical Examiners before booking.
Everything Nevada residents need to know about ketamine therapy in 2026: how it works, who oversees clinics, and how to find licensed providers.
Not all Nevada ketamine clinics are alike. Here are the key questions to ask before choosing a provider — covering licensure, safety protocols, and cost.
What Nevada patients need to know about Spravato insurance coverage in 2026: Anthem Blue Cross, Nevada Medicaid prior auth, and how to navigate the process.